DermTech Inc has a consensus price target of $4.73, established from looking at the 15 latest analyst ratings. The last 3 analyst ratings were released from Lake Street, Stephens & Co., and BTIG on April 19, 2024. With an average price target of $0.71 between Lake Street, Stephens & Co., and BTIG, there's an implied 18.33% upside for DermTech Inc from these 3 analyst ratings.
1calculated from analyst ratings published within the last 3 years
date | ticker | Buy Now | Company | Current price | Upside/Downside | Analyst Firm | Analyst & % Accurate | Price Target Change | Rating Change | Previous / Current Rating | Get Alert |
---|---|---|---|---|---|---|---|---|---|---|---|
04/19/2024 | DMTK | Buy Now | DermTech | $0.60 | 5% | Lake Street | Thomas Flaten | → $0.63 | Downgrade | Buy → Hold | Get Alert |
04/19/2024 | DMTK | Buy Now | DermTech | $0.60 | 150% | Stephens & Co. | Mason Carrico | → $1.5 | Reiterates | Equal-Weight → Equal-Weight | Get Alert |
04/19/2024 | DMTK | Buy Now | DermTech | $0.60 | — | BTIG | Sung Ji Nam | — | Downgrade | Buy → Neutral | Get Alert |
03/07/2024 | DMTK | Buy Now | DermTech | $0.60 | 233.33% | BTIG | Mark Massaro | $4 → $2 | Maintains | Buy | Get Alert |
03/05/2024 | DMTK | Buy Now | DermTech | $0.60 | 150% | Stephens & Co. | Mason Carrico | $2.5 → $1.5 | Maintains | Equal-Weight | Get Alert |
08/07/2023 | DMTK | Buy Now | DermTech | $0.60 | 733.33% | BTIG | Mark Massaro | $6 → $5 | Maintains | Buy | Get Alert |
03/29/2023 | DMTK | Buy Now | DermTech | $0.60 | 900% | TD Cowen | Max Masucci | $8 → $6 | Maintains | Outperform | Get Alert |
11/09/2022 | DMTK | Buy Now | DermTech | $0.60 | 733.33% | Stephens & Co. | Mason Carrico | $16 → $5 | Maintains | Overweight | Get Alert |
11/08/2022 | DMTK | Buy Now | DermTech | $0.60 | 900% | BTIG | Mark Massaro | $15 → $6 | Maintains | Buy | Get Alert |
11/04/2022 | DMTK | Buy Now | DermTech | $0.60 | — | William Blair | Brian Weinstein | — | Downgrade | Outperform → Market Perform | Get Alert |
08/17/2022 | DMTK | Buy Now | DermTech | $0.60 | 3733.33% | Oppenheimer | Francois Brisebois | $48 → $23 | Maintains | Outperform | Get Alert |
08/15/2022 | DMTK | Buy Now | DermTech | $0.60 | 2400% | BTIG | Mark Massaro | $19 → $15 | Maintains | Buy | Get Alert |
07/18/2022 | DMTK | Buy Now | DermTech | $0.60 | 7900% | Oppenheimer | Francois Brisebois | → $48 | Assumes | → Outperform | Get Alert |
01/07/2022 | DMTK | Buy Now | DermTech | $0.60 | — | Stephens & Co. | Mason Carrico | — | Initiates | → Overweight | Get Alert |
05/03/2021 | DMTK | Buy Now | DermTech | $0.60 | 8733.33% | BTIG | Sung Ji Nam | — | Initiates | → Buy | Get Alert |
The latest price target for DermTech (NASDAQ: DMTK) was reported by Lake Street on April 19, 2024. The analyst firm set a price target for $0.63 expecting DMTK to rise to within 12 months (a possible 5.00% upside). 6 analyst firms have reported ratings in the last year.
The latest analyst rating for DermTech (NASDAQ: DMTK) was provided by Lake Street, and DermTech downgraded their hold rating.
There is no last upgrade for DermTech.
The last downgrade for DermTech Inc happened on April 19, 2024 when Lake Street changed their price target from N/A to $0.63 for DermTech Inc.
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of DermTech, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for DermTech was filed on April 19, 2024 so you should expect the next rating to be made available sometime around April 19, 2025.
While ratings are subjective and will change, the latest DermTech (DMTK) rating was a downgraded with a price target of $0.00 to $0.63. The current price DermTech (DMTK) is trading at is $0.60, which is within the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.